Reference
Rivoirard R, et al. Clinical Impact of Bevacizumab in Patients with Relapsed Glioblastoma: Focus on a Real-Life Monocentric SurVey (SV1 Study). Chemotherapy (Basel) 61: 269-274, No. 5, 25 Feb 2016. Available from: URL: http://doi.org/10.1159/000443719 - France
Rights and permissions
About this article
Cite this article
Bevacizumab/irinotecan. Reactions Weekly 1618, 42 (2016). https://doi.org/10.1007/s40278-016-21047-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-016-21047-1